Results 51 to 60 of about 22,605 (200)

Estimation of ferrioxamine and desferrioxamine in urine [PDF]

Journal of Clinical Pathology, 1964
A method is described for the estimation of ferrioxamine and of desferrioxamine when either or both are present in urine.
J, FIELDING, M, BRUNSTROEM
openaire   +2 more sources

Quantitative Mass Spectrometry‐Based Biodistribution of Monoclonal Antibodies: An Alternative to Radio‐Biodistribution

Advanced Science, Volume 13, Issue 38, 9 July 2026.
Monoclonal antibodies are powerful anticancer therapeutics targeting tumor‐associated antigens. Mass spectrometry enables precise and accurate quantification of mAbs in tumor plasma and healthy organs. Unlike ligand binding assay and radioactivity, mass spectrometry does not suffer from matrix effects and labelling artefacts while facilitating method ...
Domenico Ravazza, Sheila Dakhel Plaza, Samuele Cazzamalli, Andrea Ciamarone, Andrea Galbiati, Riccardo Stucchi, Frederik Peissert, Emanuele Puca, Dario Neri, Ettore Gilardoni   +9 more
wiley   +1 more source

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy

Alzheimer's &Dementia, Volume 22, Issue 7, July 2026.
Abstract INTRODUCTION A subset of Alzheimer's disease (AD) patients exhibits a procoagulant state that remains undiagnosed despite available treatments. We developed positron emission tomography (PET) strategies to in vivo detect cerebral microthrombi in TgCRND8 mice. METHODS PET was performed with a fibrin‐binding probe (FBP) in TgCRND8 and wild‐type
Carlos Ceron, Marta Casquero‐Veiga, Nicolás Lamanna‐Rama, Irene Fernández‐Nueda, Alberto Fernández‐Pena, Nancy Olazagoitia, Gorka Sobrino, Aitor Herraiz, María Isabel González, María Muñoz‐Hernando, Alejandro Ruperti‐Repilado, Eduardo Romero‐Sanz, Miguel Ángel Morcillo, Carlos Pérez‐Medina, Maria Angeles Moro, Gonzalo Villaverde, Jorge Rubio, Jose Fernandez‐Ferro, Manuel Desco, Fernando Herranz, Beatriz Salinas, Valentin Fuster, Marta Cortes‐Canteli   +22 more
wiley   +1 more source

Cell membrane‐coated nanoparticles for dermatological diseases

VIEW, Volume 7, Issue 3, June 2026.
Skin disorders are challenging to treat due to complex barrier functions and limited conventional therapies. Biomimetic cell membrane‐coated nanoparticles (CM‐NPs) offer a superior nanomedicine approach by evading immune detection and enabling precise targeting.
Shuaijun Zou, Baojie Zhang, Yuanjie Zhu
wiley   +1 more source

Desferrioxamine treatment in thalassaemia: a cost utility analysis

, 2007
A cost-utility analysis was performed desferrioxamine treatment in thalctssaemia patients at two tertiary hospitals in Malaysia in 2004. A hundred and twelve transfusion dependent thalassaemia patients were grouped according to the status of ...
Husna Zayadi
core  

Evaluation of Hearing Threshold in Patients with Beta Thalasemia Major Receiving Regular ChelationTherapy with Desferrioxamine (DFO) [PDF]

Journal of Kerman University of Medical Sciences, 2005
The aim of this study was the evaluation of hearing threshold in patients with beta thalasemia major. For this purpose, 178 patients who were under regular chelation therapy with desferrioxamine (DFO) were selected and underwent ear, nose, throat ...
K Mozafarinia, Z Farahmand, M Ghazvini
doaj  

Microenvironment Modulation‐Based Nanomaterial‐Loaded Hydrogel Dressings for Diabetic Foot Ulcers: Research Progress and Future Perspectives

Advanced Materials Interfaces, Volume 13, Issue 5, 4 March 2026.
ABSTRACT Diabetic foot ulcer (DFU) is a chronic complication of diabetes, primarily caused by hyperglycemia, peripheral vascular disease, and neuropathy. Characterized by persistent hyperglycemia, impaired perfusion, inflammation, and infection, DFUs pose significant challenges to healing and are associated with high morbidity and amputation rates ...
Tang Yuqing, Chen Hong, Fan Weijing, Huang Renyan, You Yang, Liu Guobin   +5 more
wiley   +1 more source

Effect of desferrioxamine cardioplegia on ischemia-reperfusion injury in isolated rat heart

, 1997
BACKGROUND: The protective effect of desferrioxamine against myocardial ischemia-reperfusion injury remains uncertain. In this study we examined a broad range of ischemia-reperfusion indices to determine the effect of desferrioxamine cardioplegia in a ...
Nicholson, S C, Evans, R D, Squier, M, Westaby, S, Ferguson, D J, Nagy, Z; id_orcid   +5 more
core   +4 more sources

Metabolic abnormalities in patients with beta thalassemia major [PDF]

Journal of Sharif Medical & Dental College, 2018
Objective: To assess the metabolic abnormalities in patients with beta thalassemia major. Methodology: It was a cross-sectional study conducted at Department of Pathology in collaboration with Department of Orthopedic Surgery, Sharif Medical and Dental
Maria Aslam, Farooq Azam Khan, Salma Haq
doaj  

Successful desensitization of a child with desferrioxamine hypersensitivity

, 1997
Desferrioxamine is produced by a type of actinomycetes. It reacts with trivalent iron ions and forms a hydrosoluble complex called ferrioxamine B. This complex is able to remove iron from ferrous protein, but not from hemoglobin. This feature permits its
Pagliari, Gabriella, Pellegrino, Stefano, Nucera, Eleonora, Patriarca, Giampiero, Schiavino, Domenico   +4 more
core